When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LLY - European advisory group backs expanded use of Lilly's Cyramza
Eli Lilly and Company
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Eli Lilly's (NYSE:LLY) Cyramza (ramucirumab), combined with Roche (OTCQX:RHHBY) and Astellas Pharma's (OTCPK:ALPMF) Tarceva (erlotinib), for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.
More news on: Eli Lilly and Company, Roche Holding AG, Astellas Pharma Inc., Healthcare stocks news,